相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of mexiletine in non-dystrophic myotonias: A randomised, double-blind, placebo-controlled, cross-over study
Savine Vicart et al.
NEUROMUSCULAR DISORDERS (2021)
Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine
Jean-Francois Desaphy et al.
JOURNAL OF NEUROMUSCULAR DISEASES (2021)
The prevalence of hereditary neuromuscular disorders in Northern Norway
Kai Ivar Mueller et al.
BRAIN AND BEHAVIOR (2021)
Guidelines on clinical presentation and management of nondystrophic myotonias
Bas C. Stunnenberg et al.
MUSCLE & NERVE (2020)
Genotype-Phenotype Correlations and Characterization of Medication Use in Inherited Myotonic Disorders
Alayne P. Meyer et al.
FRONTIERS IN NEUROLOGY (2020)
The myotonic dystrophy experience: a North American cross-sectional study
Katharine A. Hagerman et al.
MUSCLE & NERVE (2019)
High incidence of falls in patients with myotonic dystrophy type 1 and 2: A prospective study
Joost Berends et al.
NEUROMUSCULAR DISORDERS (2019)
Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1
Nicholas E. Johnson et al.
NEUROLOGY-CLINICAL PRACTICE (2019)
Consensus-based care recommendations for adults with myotonic dystrophy type 2
Benedikt Schoser et al.
NEUROLOGY-CLINICAL PRACTICE (2019)
Myotonic dystrophy patient preferences in patient-reported outcome measures
Chad Heatwole et al.
MUSCLE & NERVE (2018)
Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands
B. C. Stunnenberg et al.
NEUROMUSCULAR DISORDERS (2018)
Falls and resulting fractures in Myotonic Dystrophy: Results from a multinational retrospective survey
A. C. Jimenez-Moreno et al.
NEUROMUSCULAR DISORDERS (2018)
A population-based epidemiologic study of adult neuromuscular disease in the Republic of Ireland
Stela Lefter et al.
NEUROLOGY (2017)
Prevalence of myotonic dystrophy type 1 in adults in western Sweden
Christopher Lindberg et al.
NEUROMUSCULAR DISORDERS (2017)
Quality of life in patients with myotonic dystrophy type 2
Vidosava Rakocevic Stojanovic et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
An Age-Standardized Prevalence Estimate and a Sex and Age Distribution of Myotonic Dystrophy Types 1 and 2 in the Rome Province, Italy
Nicola Vanacore et al.
NEUROEPIDEMIOLOGY (2016)
Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study
Sigrid Baldanzi et al.
ORPHANET JOURNAL OF RARE DISEASES (2016)
Long-term Safety and Efficacy of Mexiletine for Patients With Skeletal Muscle Channelopathies
Karen Joan Suetterlin et al.
JAMA NEUROLOGY (2015)
Myotonic dystrophy: diagnosis, management and new therapies
Chris Turner et al.
CURRENT OPINION IN NEUROLOGY (2014)
Nondystrophic myotonia: Challenges and future directions
Jaya R. Trivedi et al.
EXPERIMENTAL NEUROLOGY (2014)
The diagnosis and treatment of myotonic disorders
Chad R. Heatwole et al.
MUSCLE & NERVE (2013)
Prevalence study of genetically defined skeletal muscle channelopathies in England
Alejandro Horga et al.
NEUROLOGY (2013)
Development of a disability scale for myotonic dystrophy type 1
S. Contardi et al.
ACTA NEUROLOGICA SCANDINAVICA (2012)
Measuring quality of life impairment in skeletal muscle channelopathies
V. A. Sansone et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Mexiletine for Treatment of Myotonia A Trial Triumph for Rare Disease Networks
Eric P. Hoffman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Mexiletine for Symptoms and Signs of Myotonia in Nondystrophic Myotonia A Randomized Controlled Trial
Jeffrey M. Statland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Myotonic dystrophy type 2 (DM2) and related disorders
B. Udd et al.
NEUROMUSCULAR DISORDERS (2011)
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1
E. L. Logigian et al.
NEUROLOGY (2010)
Health supervision and anticipatory guidance in adult myotonic dystrophy type 1
C. Gagnon et al.
NEUROMUSCULAR DISORDERS (2010)
Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population
Fiona L. M. Norwood et al.
BRAIN (2009)
Differential diagnosis of myotonic disorders
Timothy M. Miller
MUSCLE & NERVE (2008)
Characterization of the pattern of cognitive impairment in myotonic dystrophy type 1
A Modoni et al.
ARCHIVES OF NEUROLOGY (2004)
Spectrum of CLCN1 mutations in patients with myotonia congenita in Northern Scandinavia
C Sun et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2001)
分享论文
